An investigation for shareholders in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares over potential wrongdoing at Pernix Therapeutics Holdings was announced and NASDAQ:PTX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/01/2015 -- An investigation for shareholders in shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Pernix Therapeutics Holdings Inc .
Investors who purchased shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Pernix Therapeutics Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Pernix Therapeutics Holdings Inc reported that its annual Total Revenue rose from $84.87 million in 2013 to $121.75 million in 2014 and that its Net Loss increased from $25.64 million to $35.29 million. Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) declined from $11.89 per share in March 2015 to as low as $2.59 per share on October 22, 2015.
On November 30, 2015, NASDAQ:PTX shares closed at $3.00 per share.
Those who purchased Pernix Therapeutics Holdings Inc shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com